| 1 | regulation of sarcomere organization (GO:0060297) | 5.96783184 |
| 2 | DNA deamination (GO:0045006) | 5.89759584 |
| 3 | respiratory chain complex IV assembly (GO:0008535) | 4.40967813 |
| 4 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 4.38158503 |
| 5 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 4.11679094 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.09902655 |
| 7 | ribonucleoprotein complex disassembly (GO:0032988) | 4.06499792 |
| 8 | negative regulation of organelle assembly (GO:1902116) | 4.06346684 |
| 9 | embryonic viscerocranium morphogenesis (GO:0048703) | 3.93610917 |
| 10 | positive regulation of gastrulation (GO:2000543) | 3.90619490 |
| 11 | rRNA catabolic process (GO:0016075) | 3.83874615 |
| 12 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.83807790 |
| 13 | regulation of skeletal muscle contraction (GO:0014819) | 3.83607446 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.82499495 |
| 15 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.82499495 |
| 16 | NADH dehydrogenase complex assembly (GO:0010257) | 3.82499495 |
| 17 | pericardium development (GO:0060039) | 3.74953289 |
| 18 | axoneme assembly (GO:0035082) | 3.74155599 |
| 19 | organelle disassembly (GO:1903008) | 3.73971733 |
| 20 | behavioral response to nicotine (GO:0035095) | 3.73385199 |
| 21 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.70899883 |
| 22 | protein polyglutamylation (GO:0018095) | 3.70456490 |
| 23 | DNA demethylation (GO:0080111) | 3.68419277 |
| 24 | negative regulation of telomere maintenance (GO:0032205) | 3.68123271 |
| 25 | adaptation of signaling pathway (GO:0023058) | 3.67226020 |
| 26 | cytochrome complex assembly (GO:0017004) | 3.64434370 |
| 27 | secondary heart field specification (GO:0003139) | 3.56428399 |
| 28 | heart field specification (GO:0003128) | 3.56428399 |
| 29 | head development (GO:0060322) | 3.55997602 |
| 30 | negative regulation of muscle hypertrophy (GO:0014741) | 3.53722972 |
| 31 | response to redox state (GO:0051775) | 3.48799901 |
| 32 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.44371664 |
| 33 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.39809954 |
| 34 | plasma membrane repair (GO:0001778) | 3.39729790 |
| 35 | protein complex biogenesis (GO:0070271) | 3.38523682 |
| 36 | protein neddylation (GO:0045116) | 3.36265658 |
| 37 | oxidative demethylation (GO:0070989) | 3.34186449 |
| 38 | cytidine metabolic process (GO:0046087) | 3.29783650 |
| 39 | cytidine catabolic process (GO:0006216) | 3.29783650 |
| 40 | cytidine deamination (GO:0009972) | 3.29783650 |
| 41 | regulation of action potential (GO:0098900) | 3.26725216 |
| 42 | positive regulation of microtubule polymerization (GO:0031116) | 3.23298000 |
| 43 | platelet dense granule organization (GO:0060155) | 3.20350036 |
| 44 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.19923516 |
| 45 | DNA dealkylation (GO:0035510) | 3.17098038 |
| 46 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.14574631 |
| 47 | kidney morphogenesis (GO:0060993) | 3.07727362 |
| 48 | negative regulation of heart growth (GO:0061117) | 3.07134403 |
| 49 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.07134403 |
| 50 | regulation of alkaline phosphatase activity (GO:0010692) | 3.06832380 |
| 51 | striated muscle atrophy (GO:0014891) | 3.04963366 |
| 52 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.04450429 |
| 53 | cornea development in camera-type eye (GO:0061303) | 3.03815749 |
| 54 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.03338844 |
| 55 | response to pheromone (GO:0019236) | 3.03311443 |
| 56 | rRNA modification (GO:0000154) | 3.02002850 |
| 57 | nodal signaling pathway (GO:0038092) | 3.01669343 |
| 58 | regulation of cilium movement (GO:0003352) | 2.97033944 |
| 59 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.96857153 |
| 60 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.95000825 |
| 61 | protein localization to cilium (GO:0061512) | 2.94531943 |
| 62 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.90964425 |
| 63 | protein targeting to vacuole (GO:0006623) | 2.88893837 |
| 64 | protein targeting to lysosome (GO:0006622) | 2.88893837 |
| 65 | establishment of protein localization to vacuole (GO:0072666) | 2.88893837 |
| 66 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.88762603 |
| 67 | multicellular organism reproduction (GO:0032504) | 2.87561745 |
| 68 | somite rostral/caudal axis specification (GO:0032525) | 2.86713187 |
| 69 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.85258469 |
| 70 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.85223202 |
| 71 | positive regulation of immune response to tumor cell (GO:0002839) | 2.82385344 |
| 72 | regulation of immune response to tumor cell (GO:0002837) | 2.82385344 |
| 73 | regulation of response to tumor cell (GO:0002834) | 2.82385344 |
| 74 | positive regulation of response to tumor cell (GO:0002836) | 2.82385344 |
| 75 | glomerulus development (GO:0032835) | 2.81755296 |
| 76 | protein K6-linked ubiquitination (GO:0085020) | 2.81282521 |
| 77 | glycerophospholipid catabolic process (GO:0046475) | 2.79331099 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 2.78467918 |
| 79 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.78137624 |
| 80 | membrane raft organization (GO:0031579) | 2.78117180 |
| 81 | regulation of membrane repolarization (GO:0060306) | 2.77805756 |
| 82 | adult feeding behavior (GO:0008343) | 2.75307064 |
| 83 | negative regulation of protein localization to cell surface (GO:2000009) | 2.71414251 |
| 84 | replication fork processing (GO:0031297) | 2.70561005 |
| 85 | maturation of 5.8S rRNA (GO:0000460) | 2.69447262 |
| 86 | nephron epithelium morphogenesis (GO:0072088) | 2.69241919 |
| 87 | nephron tubule morphogenesis (GO:0072078) | 2.69241919 |
| 88 | rRNA methylation (GO:0031167) | 2.69102944 |
| 89 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.67143488 |
| 90 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.66938382 |
| 91 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.65773824 |
| 92 | short-term memory (GO:0007614) | 2.65314540 |
| 93 | cellular response to interferon-beta (GO:0035458) | 2.64926535 |
| 94 | muscle atrophy (GO:0014889) | 2.64332955 |
| 95 | retina layer formation (GO:0010842) | 2.63658935 |
| 96 | NAD biosynthetic process (GO:0009435) | 2.63252976 |
| 97 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.63194958 |
| 98 | renal tubule morphogenesis (GO:0061333) | 2.62242655 |
| 99 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.61213455 |
| 100 | pseudouridine synthesis (GO:0001522) | 2.61174419 |
SEPT7P1 
